District of Columbia § 48-843.03 Establishment of the Pharmaceutical Education Program.

District of Columbia Statutes

§ 48-843.03 — Establishment of the Pharmaceutical Education Program.

District of Columbia § 48-843.03

Title 48Foods and Drugs.

Ch. 8DPharmaceutical Education Program.

This text of District of Columbia § 48-843.03 (Establishment of the Pharmaceutical Education Program.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

D.C. Code § 48-843.03 (2026).

Text

(a)There is established an evidence-based Pharmaceutical Education Program (“Program”) within the Department of Health. The Program shall:

(1)Educate prescribers who participate in the District of Columbia Medicaid program, and other publicly funded, contracted, or subsidized health-care programs, on the therapeutic and cost-effective utilization of pharmaceutical products;

(2)Inform prescribers about pharmaceutical product marketing practices that are intended to circumvent competition from generic, other therapeutically-equivalent alternatives, or other evidence-based treatment options; and

(3)Utilize, or incorporate into the Program, other independent educational resources or models proven effective in promoting high-quality, evidenced-based, cost-effective information rega

Free access — add to your briefcase to read the full text and ask questions with AI

(a) There is established an evidence-based Pharmaceutical Education Program (“Program”) within the Department of Health. The Program shall:

(1) Educate prescribers who participate in the District of Columbia Medicaid program, and other publicly funded, contracted, or subsidized health-care programs, on the therapeutic and cost-effective utilization of pharmaceutical products;

(2) Inform prescribers about pharmaceutical product marketing practices that are intended to circumvent competition from generic, other therapeutically-equivalent alternatives, or other evidence-based treatment options; and

(3) Utilize, or incorporate into the Program, other independent educational resources or models proven effective in promoting high-quality, evidenced-based, cost-effective information regarding the effectiveness and safety of pharmaceutical products.

(b) The Program shall be made available to prescribers who do not participate in the District of Columbia Medicaid program or other publicly funded, contracted, or subsidized health-care programs on a subscription basis.

(c) If approved by the Board of Medicine, the PE program may be used to satisfy continuing education requirements for the practice of medicine.